The water is choppy for ITM Power after a spectacular run. The stock careered 7.07% lower to 194.40 pence on Wednesday, pulling back from a 52-week high of 219.80 pence just a day earlier. The volume told the story: nearly 27.6 million shares changed hands against a daily average of 6.58 million. No company-specific trigger was obvious, suggesting profit-taking after a near-vertical climb of 295.73% from the February trough of 46 pence.
Yet for all the short-term noise, the real plot lies in the weeks ahead. June is shaping up as a month of reckoning, with three pivotal decisions that will test whether the recent rerating has operational substance behind it. And unlike many hydrogen peers burning through cash, ITM sits on a net liquidity position of £215 million — a formidable cushion in a capital-intensive industry.
Chronos: The Big Bet on Cost Reduction
The most consequential call is the final investment decision on the Chronos programme. ITM’s next-generation electrolyser system delivers 2 MW per unit, tripling the output of its predecessor while slashing costs by 40% and halving the footprint. The company has already secured a £46.5 million government grant for the project, plus a £40 million equity injection from Great British Energy in April. Commercial production is slated for 2028 at the new Sheffield gigawatt factory.
The timing is deliberate. Management said the FID would come shortly after the grant was confirmed. With that box ticked, the decision is now imminent.
HAR2 and Humber: Two More Levers
Alongside Chronos, the outcome of the UK’s second hydrogen allocation round, HAR2, will be critical. Twenty-seven projects are on the shortlist, and ITM has already locked in preferred-supplier status for two of them — one large and one smaller — though both remain subject to final investment decisions. Formal contract awards are expected by the end of 2026.
Then there is Uniper’s Humber H2ub project at Killingholme. ITM is lined up to supply six POSEIDON modules at 20 MW each for the initial 120 MW phase, with first operations pencilled in for 2029. The site could later scale to over 200 MW, offering a potential long-term revenue stream.
Numbers Are Improving, but Red Ink Persists
Operationally, the Sheffield-based company is making tangible progress. Revenue for FY2026 is guided at £40–43 million, representing growth of around 35%. The first half alone delivered a record £18 million in sales. The adjusted EBITDA loss narrowed to £11.9 million from £16.8 million a year earlier, though the full-year deficit is still expected at £27–29 million and the pretax loss widened to £45.4 million.
Should investors sell immediately? Or is it worth buying ITM Power?
The order book stands at £152 million, of which 71% is classified as mature contracts — a sign that project visibility is improving. That matters for a company that has historically suffered from lumpy demand and delays.
Analyst Opinions: A Tale of Two Cities
The analyst community remains sharply divided. Jefferies lifted its price target to 200 pence and kept a buy rating, citing stronger fundamentals and clearer pipeline visibility. Morgan Stanley went one step further, upgrading to Overweight — the first positive rating on a hydrogen OEM since 2021. The bank now sees EBITDA breakeven in FY2028, a year earlier than previous estimates, provided ITM books around 200 MW of new orders.
But not everyone is convinced. Berenberg maintains a buy but with a target of only 110 pence, while UBS stays neutral at 60 pence. The wide spread reflects the inherent uncertainty around the pace of hydrogen adoption.
International Validation
Beyond the UK pipeline, ITM picked up a vote of confidence on the global stage. The REFHYNE-2 project — a 100 MW electrolyser for Shell’s Energy and Chemicals Park Rhineland in Germany — won two awards at the World Hydrogen Summit in Rotterdam: the Clean Hydrogen Project Award and the Industrial Application Award. From 2027, the plant is expected to produce up to 44,000 kilograms of renewable hydrogen daily, partly to decarbonise Shell’s Wesseling refinery.
What Lies Ahead
The stock has already rallied 164% in three months, outpacing Ballard Power (+163%), Plug Power (+105%) and NEL ASA (+70%). That sort of move invites scepticism, but the narrowing losses and £215 million of net liquidity give ITM a war chest that most hydrogen plays lack.
All three June decisions — Chronos FID, HAR2 allocations and the Uniper vote — should be known before the company reports its full-year results on 15 September 2026. By then the market will have a much clearer view of whether the recent euphoria was a genuine inflection point or just another short-lived hydrogen flare-up.
Ad
ITM Power Stock: Buy or Sell?! New ITM Power Analysis from June 2 delivers the answer:
The latest ITM Power figures speak for themselves: Urgent action needed for ITM Power investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 2.
ITM Power: Buy or sell? Read more here...
